Immunological escape mechanism in spontaneously metastasizing mammary tumors
- PMID: 48247
- PMCID: PMC432454
- DOI: 10.1073/pnas.72.3.1012
Immunological escape mechanism in spontaneously metastasizing mammary tumors
Abstract
Immunological and biochemical studies of spontaneously metastasizing and nonmetastasizing rat mammary carcinomas and their plasma membranes indicated that: (i) all spontaneously metastasizing tumors have little or no demonstrable glycocalyx, while all nonmetastasizing tumors have a thick glycocalyx; (ii) there is a direct relationship between the glycocalyx and immunogenicity, and an inverse relationship with the metastasizing capacity of tumor cells, properties which can be quantitated by levels of the plasma membrane marker enzyme 5'-nucleotidase (EC3.1.3.5;5'-ribonucleotide phosphohydrolase) activity; (iii) the absence of glycocalyx from the metastasizing tumor cell surface seems to result from its dissociation from plasma membranes, for solubilized cell surface antigen is readily found in the blood of metastasizing tumor bearing rats, while there was no detectable tumor cell surface antigen in the blood of the nonmetastasizing tumor hosts tested; (iv) both metastasizing and nonmetastasizing mammary tumors appear to have a common soluble cell surface antigen; (v) in addition to this common antigen, there is another membrane-bound antigen in the nonmetastasizing, immunogenic tumor cell surface which presumably is the tumor specific transplantation antigen; and (vi) this antigen is immunobiologically unique, but seems to be immunochemically related to the common soluble antigen. It is postulated that the lack of an immunogenic coat and/or the presence of solubilized tumor cell surface antigen in the blood may provide an immune escape mechanism for tumor cells by interfering with cell-mediated immune response of tumor hosts, leading to their dissemination.
Similar articles
-
Galactosyltransferase activity in metastasizing and nonmetastasizing rat mammary carcinomas and its possible relationship with tumor cell surface antigen shedding.J Natl Cancer Inst. 1977 Feb;58(2):273-80. doi: 10.1093/jnci/58.2.273. J Natl Cancer Inst. 1977. PMID: 833875
-
Adenosine-3',5'-cyclic monophosphate levels and adenosine-3',5'-cyclic monophosphate phosphodiesterase activity in metastasizing and nonmetastasizing rat mammary carcinomas.J Natl Cancer Inst. 1975 Jan;54(1):181-6. doi: 10.1093/jnci/54.1.181. J Natl Cancer Inst. 1975. PMID: 163315
-
Plasma membrane associated enzymes of mammary tumours as the biochemical indicators of metastasizing capacity. Analyses of enriched plasma membrane preparations.Br J Cancer. 1976 Jan;33(1):15-26. doi: 10.1038/bjc.1976.3. Br J Cancer. 1976. PMID: 175819 Free PMC article.
-
Fucosyltransferase activity in metastasizing and nonmetastasizing rat mammary carcinomas.J Natl Cancer Inst. 1978 Jul;61(1):151-62. doi: 10.1093/jnci/61.1.151. J Natl Cancer Inst. 1978. PMID: 78984
-
Presence of a specific immune complex in the cell-free ascites of a spontaneously metastasizing rat mammary adenocarcinoma, TMT-081.Immunol Commun. 1984;13(1):63-76. doi: 10.3109/08820138409025450. Immunol Commun. 1984. PMID: 6735434
Cited by
-
Antigen shedding by human breast-cancer cells in vitro and in vivo.Br J Cancer. 1978 May;37(5):776-9. doi: 10.1038/bjc.1978.115. Br J Cancer. 1978. PMID: 656305 Free PMC article.
-
Host immunity to mycoplasma antigens introduced into B16 melanoma cells: effect on tumor growth rate and metastasis.Clin Exp Metastasis. 1988 Jul-Aug;6(4):271-84. doi: 10.1007/BF01753574. Clin Exp Metastasis. 1988. PMID: 3129225
-
Properties of metastatic and nonmetastatic cloned subpopulations of an ultraviolet-light-induced murine fibrosarcoma of recent origin.Am J Pathol. 1979 Dec;97(3):633-48. Am J Pathol. 1979. PMID: 507195 Free PMC article.
-
Synthetic self-adjuvanting glycopeptide cancer vaccines.Front Chem. 2015 Oct 23;3:60. doi: 10.3389/fchem.2015.00060. eCollection 2015. Front Chem. 2015. PMID: 26557640 Free PMC article. Review.
-
Lewis lung carcinoma (3LL) cells treated in vitro with ultraviolet radiation show reduced metastatic ability due to an augmented immunogenicity.Clin Exp Metastasis. 1987 Jan-Mar;5(1):43-56. doi: 10.1007/BF00116625. Clin Exp Metastasis. 1987. PMID: 3829496
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials